The PE Ratio as of November 2024 (TTM) for Lisata Therapeutics, Inc. (LSTA) is -1.15

According to Lisata Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -1.15. This represents a change of -7.13% compared to the average of -1.24 of the last 4 quarters.

Lisata Therapeutics, Inc. (LSTA) Historical PE Ratio (quarterly & annually)

How has LSTA PE Ratio performed in the past?

The mean historical PE Ratio of Lisata Therapeutics, Inc. over the last ten years is -1.11. The current -1.15 PE Ratio has changed 10.22% with respect to the historical average. Over the past ten years (40 quarters), LSTA's PE Ratio was at its highest in in the June 2020 quarter at 0.89. The PE Ratio was at its lowest in in the December 2019 quarter at -20.18.

Lisata Therapeutics, Inc. (LSTA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Lisata Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lisata Therapeutics, Inc. (LSTA) Average PE Ratio

How has LSTA PE Ratio performed in the past?

The current PE Ratio of Lisata Therapeutics, Inc. (LSTA) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Lisata Therapeutics, Inc. (LSTA) PE Ratio vs. Peers

How is LSTA’s PE Ratio compared to its peers?

Lisata Therapeutics, Inc.’s PE Ratio is less than Lixte Biotechnology Holdings, Inc. (-0.92), less than Histogen Inc. (-0.01), less than Imunon, Inc. (-0.00), less than Kineta, Inc. (-0.36), greater than Rezolute, Inc. (-4.94), greater than Cyteir Therapeutics, Inc. (-9.12), greater than XOMA Corporation (-11.81), less than Protagenic Therapeutics, Inc. (-0.52), less than Tempest Therapeutics, Inc. (-0.66), greater than Pulmatrix, Inc. (-2.31), greater than Onconova Therapeutics, Inc. (-1.15), greater than Catalyst Biosciences, Inc. (-4.80), less than Bio-Path Holdings, Inc. (-0.24), less than Moleculin Biotech, Inc. (-0.34), greater than Alpine Immune Sciences, Inc. (-112.94), less than AN2 Therapeutics, Inc. (-0.66), less than Ampio Pharmaceuticals, Inc. (-0.00), greater than Monte Rosa Therapeutics, Inc. (-5.83), greater than Candel Therapeutics, Inc. (-3.09),

Build a custom stock screener for Lisata Therapeutics, Inc. (LSTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lisata Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lisata Therapeutics, Inc. (LSTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lisata Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.